This 32-year-old man presenting with hypertrophic cardiomyopathy underwent implantation of a single chamber Boston Science Teligen defibrillator for management of VT associated with syncope. He was seen for the complaint of palpitation and near syncope followed by the delivery of an electrical shock.
Summary
Episode of tachyarrhythmia at a rate of 259 bpm, diagnosed in the VF zone treated with a maximum 41-J electrical shock.
Tracing
The current consensus is to treat organized ventricular tachyarrhythmias by ATP instead of electrical shocks. This is because a large proportion of episodes at rates >200 bpm, diagnosed as VF by the defibrillator, actually consist of rapid monomorphic VT, which can be successfully ended by programmed ventricular stimulation. Since ATP is painless, lowers the energy consumption and spares the batteries, it must be given priority as first-line therapy for organized ventricular rhythms, even when they are very rapid. However, the delivery of an electrical shock is sometimes inescapable, though not harmless, aggravating the patient’s prognosis with its own deleterious consequences (probable myocardial injury). In this patient, rapid, monomorphous VT was detected in the VF zone and treated outright with an electrical shock of maximum strength. A non-programmable rate limit of ≤250 bpm for the delivery of Quick Convert bursts of ATP has been assigned to this type of defibrillator. This limit prevents the delivery of ATP for non-physiologic, often very rapid pseudo-tachycardias observed with lead fractures or with P, R or T wave oversensing.